Circulating tumor cells in melanoma patients

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Clawson, Gary A ^a,b   Kimchi, Eric ^a   Patrick, Susan D ^a   Xin, Ping ^a   Harouaka, Ramdane ^b   Zheng, Siyang ^b   Berg, Arthur ^a   Schell, Todd ^a   Staveley O'Carroll, Kevin F ^a   Neves, Rogerio I ^a   Mosca, Paul J ^c   Thiboutot, Diane ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; CYTOKERATIN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MIGRATION INHIBITION FACTOR; MONOPHENOL MONOOXYGENASE; RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CELL CULTURE; CELL MIGRATION; CELL POPULATION; CENTRIFUGATION; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FILTER; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LEUKOCYTE; MALE; MELANOCYTE; MELANOMA; MICROTECHNOLOGY; PANCREAS CANCER; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ADULT; ANTIGENS, CD14; ANTIGENS, CD45; FEMALE; HUMANS; MALE; MELANOMA; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84864053180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041052     Document Type: Article

References (53)

1. Danila DC, Fleisher M, Scher HI, (2011) Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res 17: 3903-3912.
2. Lianidou ES, Markou A, (2011) Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 49: 1579-1590.
3. Sioss JA, Bhiladvala R, Pan W, Li M, Patrick S, et al. (2011) Nanoresonator Chip-based RNA Sensor Strategy for Detection of Circulating Tumor Cells: Response using PCA3 as a Prostate Cancer Marker. Nanomedicine: Nanotechnology, Biology, and Medicine in Press.
4. Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, et al. (2005) Molecular diagnostics in melanoma. J Am Acad Dermatol 52: 743-775.
5. Tsao H, Nadiminti U, Sober AJ, Bigby M, (2001) A Meta-analysis of Reverse Transcriptase-Polymerase Chain Reaction for Tyrosinase mRNA as a Marker for Circulating Tumor Cells in Cutaneous Melanoma. Arch Dermatol 137: 325-330.
6. Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, et al. (2005) Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy from stage III melanoma: outcome prediction in a multicenter trial. J Clin Oncol 23: 8057-8064.
7. De Giorgi V, Pinzani P, Salvianti F, Panelos J, Paglierani M, et al. (2010) Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Invest Dermatol 130: 2440-2447.
8. Ireland A, Millward M, Pearce R, Lee M, Ziman M, (2011) Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Clin Exp Metastasis 28: 327-336.
9. Fusi A, Ochsenreither S, Busse A, Reitz A, Keilholz U, (2010) Stem cell marker nestin expression inperipheral blood of patients with melanoma. Br J Dermatol Mar 24 (ePub ahead of print).
10. Samija I, Lukac J, Maric-Brozic J, Builjan M, Alajbeg I, et al. (2010) Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma. Melanoma Res 20: 293-302.
11. Xi L, Nicastri DG, El-Hernawy T, Hughes SJ, Luketich JD, et al. (2007) Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem 53: 1206-1215.
12. Mocellin S, Del Fiore P, Guarnieri L, Scalerta R, Foletto M, et al. (2004) Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer 111: 741-745.
13. Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, et al. (2003) Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/Mart-1 reverse transcriptionpolymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 97: 1737-1745.
14. Curry BJ, Myers K, Hersey P, (1999) MART-1 is Expressed Less Frequently on Circulating Melanoma Cells in Patietns Who Develop Distant Compared with Locoregional Metrastases. J Clin Oncol 17: 2562-2571.
15. Kitago M, Kovanagi K, Nakamura T, Goto Y, Faries M, et al. (2009) mRNA expression and BRAF mutation in circulating melanoma cells isolated fromperipheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. Clin Chem 55: 757-764.
16. Yasasever V, Camlica H, Duranyildiz D, Oguz H, Tas F, et al. (2007) Macrophage migration inhibitory factor in cancer. Cancer Invest 25: 715-719.
17. Lee H, Rhee H, Kang HJ, Kim H-S, Min BS, et al. (2008) Macrophage Migration Inhibitory Factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol 129: 772-779.
18. Yao K, Shida S, Selvakumaran M, Zimmerman RM, Simon E, et al. (2005) Macrophage Migration Inhibitory Factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines. Clin Cancer Res 11: 7264-7272.
19. Bifulco C, McDaniel K, Leng L, Bucala R, (2008) Tumor growth-promoting properties of macrophage migration inhibitory factor. Curr Pharm Des 14: 3790-3801.
20. Bach JP, Rinn B, Dodel R, Bacher M, (2008) Role of MIF in inflammation and tumorigenesis. Oncology 75: 127-133.
21. Konigsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, et al. (2011) Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 50: 700-710.
22. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, et al. (2010) Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10: 666.
23. Lagoudianakis EE, Kataki A, Manouras A, Memos N, Papadima A, et al. (2009) Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. J Surg Res 155: 183-190.
24. Sable MS, Liu Y, Griffith KA, He J, Xie X, et al. (2011) Clinical utility of serum autoantibodies detected by protein microarray in melanoma. Int J Proteomics 2011: 413742.
25. Pinzani P, Salvianti F, Zaccara S, Massi D, De Giorgi V, et al. (2011) Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. Clin Chim Acta 412: 2141-2145.
26. Klingenstein A, JHaritoglou I, Schaumberger MM, Nentwich MM, Hein R, et al. (2011) Receiver operating characteristic analysis: calculation for the marker 'melanoma inhibitory activity' in metastatic uveal melanoma patients. Melanoma Res 21: 352-356.
27. Lu B, Zheng S, Xie S, Tai Y-C (2009, Jeju Korea) Live capture of Circulating Tumor Cells from human blood by a splitable 3D parylene membrane filtration device. Proc (Thirteenth International Conference on Minaturized Systems for Chemistry and Life Sciences) 13: 588-590.
28. Itakura E, Huang RR, Wen DR, Cochran AJ, (2011) "Stealth" melanoma cells in histology-negative sentinel lymph nodes. Am J Surg Pathol 35: 1657-1665.
29. Mocellin S, Hoon DS, Ambrosi A, Nitti D, Rossi CR, (2006) The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res 12: 4605-4613.
30. Steen S, Nemunaitis J, Fisher T, Kuhn J, (2008) Circulating tumor cells in melanoma: a review of the literature and description of a novel technique. Proc (Bay Univ Med Cent) 21: 127-132.
31. Lee J, Lee J, Roh K, Kim M-O, Kim J-D, et al. (2010) Conditions for the differentiation of melanocyte-precursor cells from human cord blood-derived mesenchymal stem cells. African J Biotechnology 9: 5975-5977.
32. Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, et al. (2011) Generation of human melanocytes from induced pluripotent stem cells. PLos One 6: e16182.
33. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, et al. (2000) A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 60: 2512-2519.
34. Pawelek JM, Chakraborty AK, (2008) The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res 101: 397-444.
35. Rachkovsky M, Sodi S, Chakraborty AK, Avissar Y, Bolognia J, et al. (1998) Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16: 299-312.
36. Sodi SA, Chakraborty AK, Platt JT, Kolesnikova N, Rosenblat S, et al. (1998) Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: N-glycosylation as an underlying mechanism. Pigment Cell Res 11: 299-309.
37. Rupani R, Handerson T, Pawelek JM, (2004) Co-localization of b1, 6-branched oligosaccharides and coarse melanin in macrophage-melanoma fusion hybrids and human melanoma cells in vitro. Pigment Cell Res 17: 281-288.
38. Lugini L, Lozupone F, Matarrese P, Funaro C, Luciani F, et al. (2003) Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest 83: 1555-1567.
39. Chen N, Gong J, Chen X, Xu M, Huang Y, et al. (2009) Ctyokeratin expression in malignant melanomas: potential application of in-situ hybridization analysis of mRNA. Melanoma Res 19: 87-93.
40. Gatter KC, Ralfkiaer E, Skinner J, Brown D, Heryet A, et al. (1985) An immmunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J Clin Pathol 38: 1353-1357.
41. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE, (1996) Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 15: 507-525.
42. Hendrix MJ, Seftor EA, Chu YW, Seftor RE, Nagle RB, et al. (1992) Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst 84: 165-174.
43. Singh T, Katiyar SK, (2011) Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. PLoS One 6: e25224.
44. Duelli D, Lazebnik Y, (2003) Cell fusion: a hidden enemy? Cancer Cell 3: 445-448.
45. Kluk MJ, Grant-Kels JM, Kerr P, Hoss D, Berke A, et al. (2004) Melanoma on the move: the progression of melanoma; novel concepts and histologic correlates. Am J Dermatopathol 26: 504-510.
46. Pawelek JM, Chakraborty AK, (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8: 377-386.
47. Pawelek JM, (2005) Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6: 988-993.
48. Pawelek JM, (2000) Tumour cell hybridization and metastasis revisited. Melanoma Res 10: 507-514.
49. Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, et al. (2008) Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102: 521-534.
50. Erin N, Wang N, Xin P, Bui V, Weisz J, et al. (2009) Altered gene expression in breast cancer liver metastases. Int J Cancer 124: 1503-1516.
51. Pan W, Xin P, Morrey J, Clawson G, (2004) A Self-Processing Ribozyme Cassette: Utility against Human Papillomavirus 11 E6/E7 mRNA and Hepatitis B virus. Mol Therapy 9: 596-606.
52. Sing T, Sander O, Beerenwinkel N, Lengauer T, (2009) ROCR: Visualizing the performance of scoring classifiers. R Package version 1.0-4 ed.
53. Team RDC (2011) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.